Duopharma to gain from consumer healthcare sales

UOBKH Research said the securing of government contracts on improved terms and concession renewal augur well for the company.

PETALING JAYA: Recent developments are looking promising for Duopharma Biotech Bhd, according to UOB Kay Hian (UOBKH) Research.

The securing of government contracts on improved terms and concession renewal as well as the potential growth in consumer healthcare sales are auguring well for the company, said the research house.